SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 64 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,525,000 | -14.2% | 1,268,946 | 0.0% | 0.24% | -14.6% |
| Q4 2019 | $8,768,000 | -33.4% | 1,268,946 | 0.0% | 0.28% | -47.9% |
| Q3 2019 | $13,172,000 | +12.1% | 1,268,946 | 0.0% | 0.54% | +27.3% |
| Q2 2019 | $11,750,000 | +1.3% | 1,268,946 | +0.0% | 0.42% | -5.2% |
| Q1 2019 | $11,598,000 | +64.1% | 1,268,945 | 0.0% | 0.44% | +57.2% |
| Q4 2018 | $7,068,000 | -53.2% | 1,268,945 | 0.0% | 0.28% | -47.7% |
| Q3 2018 | $15,113,000 | +16.6% | 1,268,945 | 0.0% | 0.54% | +18.9% |
| Q2 2018 | $12,956,000 | -21.3% | 1,268,945 | 0.0% | 0.46% | -20.3% |
| Q1 2018 | $16,471,000 | +33.4% | 1,268,945 | 0.0% | 0.57% | +17.5% |
| Q4 2017 | $12,347,000 | -33.9% | 1,268,945 | 0.0% | 0.49% | -42.2% |
| Q3 2017 | $18,679,000 | -8.5% | 1,268,945 | 0.0% | 0.84% | -22.8% |
| Q2 2017 | $20,417,000 | -20.6% | 1,268,945 | -21.4% | 1.09% | +9.8% |
| Q1 2017 | $25,729,000 | +16.7% | 1,615,136 | -10.9% | 0.99% | +9.4% |
| Q4 2016 | $22,043,000 | -12.3% | 1,812,778 | 0.0% | 0.91% | -22.4% |
| Q3 2016 | $25,143,000 | -33.9% | 1,812,778 | -13.5% | 1.17% | -21.8% |
| Q2 2016 | $38,028,000 | – | 2,095,220 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |